Interestingly, Adar1-/- tumors are sensitized to anti-tumor immunity and IFNβ and γ treatment (48); moreover, Adar1 depletion allows to overcome different mechanisms of acquired resistance to immunotherapy with a significant increase in immune cells infiltration, including non-MHC I-restricted cytotoxic cells (48). This evidence concerns the gene ADAR and neoplasm.